Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol

British Journal of Haematology

Volumn 165, Issue 4, 2014, Pages 552-555

  Patrick, Katharine ^a   Wade, Rachel ^b   Goulden, Nicholas ^c   Rowntree, Clare ^d   Hough, Rachael ^e   Moorman, Anthony V ^f   Mitchell, Christopher D ^g   Vora, Ajay ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Down syndrome; Lymphoblastic leukaemia; Treatment

Indexed keywords

DOWN SYNDROME; LYMPHOBLASTIC LEUKAEMIA; TREATMENT;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; DISEASE-FREE SURVIVAL; DOWN SYNDROME; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFECTION; MALE; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; RISK ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899488064     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12739     Document Type: Article

References (11)

1. Bassal, M., La, M.K., Whitlock, J., Sather, H., Heerema, N., Gaynon, P. & Stork, L. (2005) Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952. Pediatric Blood & Cancer, 44, 21-28.
2. Buitenkamp, T., Pieters, R., Gallimore, N., van der Veer, A., Meijerink, J., Beverloo, H., Zimmermann, M., de Haas, V., Richards, S., Vora, A., Mitchell, C., Russell, L., Schwab, C., Harrison, C., Moorman, A., van den Heuvel-Eibrink, M., den Boer, M. & Zwaan, C. (2012) Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia, 26, 2204-2211.
3. Chessells, J., Harrison, G., Richards, S., Bailey, C., Hill, F., Gibson, B. & Hann, I. (2001) Down's syndrome and acute lymphoblastic leukaemia : clinical features and response to treatment. Archives of Disease in Childhood, 85, 321-325.
4. Dordelmann, M., Schrappe, M., Reiter, A., Zimmermann, M., Graf, N., Schott, G., Lampert, F., Harbott, J., Niemeyer, C., Ritter, J., Dorffell, W., Nessler, G., Kuhl, J. & Riehm, H. (1998) Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Leukemia, 12, 645-651.
5. Fong, C. & Brodeur, G. (1987) Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genetics and Cytogenetics, 28, 55-76.
6. Hasle, H., Clemmensen, I. & Mikkelsen, M. (2000) Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet, 355, 165-169.
7. Maloney, K. (2011) Acute lymphoblastic leukaemia in children with Down syndrome: an updated review. British Journal of Haematology, 155, 420-425.
8. Moorman, A., Ensor, H., Richards, S., Chilton, L., Schwab, C., Kinsey, S., Vora, A., Mitchell, C. & Harrison, C. (2010) Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. The Lancet Oncology, 11, 429-438.
9. Schwab, C.J., Chilton, L., Morrison, H., Jones, L., Al-Shehhi, H., Erhorn, A., Russell, L.J., Moorman, A.V. & Harrison, C.J. (2013) Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica, 98, 1081-1088.
10. Vora, A., Goulden, N., Wade, R., Mitchell, C., Hancock, J., Hough, R., Rowntree, C. & Richards, S. (2013) Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. The Lancet Oncology, 14, 199-209.
11. Whitlock, J., Sather, H., Gaynon, P., Robison, L., Wells, R., Trigg, M., Heerema, N. & Bhatia, S. (2005) Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Blood, 106, 4043-4049.